Zhang Shaosen, Wang Caihong, Ju Jiujun, Wang Caixia
Department of Etiology and Carcinogenesis, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Front Oncol. 2022 Jun 30;12:906080. doi: 10.3389/fonc.2022.906080. eCollection 2022.
Tumor-secreted proteins can provide numerous molecular targets for cancer diagnosis and treatment. Of note, pyruvate kinase M2 (PKM2) is secreted by tumor cells to promote malignant progression, while its regulatory mechanism or the interacting network remains uncovered. In the present study, we identified extracellular heat shock protein 90 alpha (eHsp90α) as one potential interacting protein of ePKM2 by mass spectrometry (MS), which was further verified by pull-down and co-immunoprecipitation analysis. Later, we found that eHsp90α enhanced the effect of ePKM2 on migration and invasion of lung cancer cells. Blocking of Hsp90α activity, on the other hand, attenuated tumor migration or invasion induced by ePKM2. Eventually, the role of Hsp90α in regulating ePKM2 activity was validated by the mouse xenograft tumor model. Mechanistically, we found that eHsp90α binds to and stabilizes ePKM2 to protect it from degradation in the extracellular environment. Besides, eHsp90α promoted the interaction of ePKM2 with cell surface receptor GRP78, which leads to the activation of the ePKM2/GRP78/AKT axis. Collectively, we unraveled the novel molecular mechanism of eHsp90α in regulating ePKM2 activity during tumor progression, which is beneficial for the development of new treatments against lung cancer.
肿瘤分泌的蛋白质可为癌症诊断和治疗提供众多分子靶点。值得注意的是,丙酮酸激酶M2(PKM2)由肿瘤细胞分泌以促进恶性进展,但其调控机制或相互作用网络仍未明确。在本研究中,我们通过质谱(MS)鉴定细胞外热休克蛋白90α(eHsp90α)为ePKM2的一种潜在相互作用蛋白,并通过下拉实验和免疫共沉淀分析进一步验证。随后,我们发现eHsp90α增强了ePKM2对肺癌细胞迁移和侵袭的作用。另一方面,阻断Hsp90α活性可减弱ePKM2诱导的肿瘤迁移或侵袭。最终,通过小鼠异种移植瘤模型验证了Hsp90α在调节ePKM2活性中的作用。机制上,我们发现eHsp90α与ePKM2结合并使其稳定,以保护其在细胞外环境中不被降解。此外,eHsp90α促进ePKM2与细胞表面受体GRP78的相互作用,从而导致ePKM2/GRP78/AKT轴的激活。总体而言,我们揭示了eHsp90α在肿瘤进展过程中调节ePKM2活性的新分子机制,这有利于开发针对肺癌的新疗法。